Choice of  Noninferiority Margin and Dependency of the Noninferiority Trials

By Tsong Yi   Zhang Joanne   Levenson Mark  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 2, 2007-03 ,pp. : 279-288

Taylor & Francis Ltd

Access to resources Recommend Favorite

Simultaneous Test for Superiority and Noninferiority Hypotheses in Active-Controlled Clinical Trials

By Tsong Yi   Zhang Joanne  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 2, 2007-03 ,pp. : 247-257

Taylor & Francis Ltd

Access to resources Recommend Favorite

The Utility of Active-Controlled Noninferiority/Equivalence Trials in Drug Development

By Tsong Yi  

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 3, 2007-01 ,pp. : 225-233

Adis International

Access to resources Recommend Favorite

The Adjustment of the Type I Error Rate in Noninferiority Trials with -Margin Approach: Each of Two Different New Drugs is Approved with Two Independent Trials with the Same Active Control

By Kang Seung-Ho   Ryu Yuman  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 3, 2011-05 ,pp. : 498-510

Taylor & Francis Ltd

Access to resources Recommend Favorite

Strength of Evidence of Noninferiority Trials with the Two Confidence Interval Method with Random Margin

By Wang So-Young  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 2, 2013-03 ,pp. : 307-321

Taylor & Francis Ltd

Access to resources Recommend Favorite